General Hospital Of Shenyang Military Region
Clinical trials sponsored by General Hospital Of Shenyang Military Region, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Does the clock matter? trial tests endoscopy timing for cirrhosis bleeding Results expected Oct 2026 (estimated)
- Simple cuff therapy may boost brain blood flow after stroke Results expected Nov 2026 (estimated)
- Ultrasound during artery stenting may cut stroke risk Results expected Nov 2026 (estimated)
- Stem cells for failing livers: does the delivery route matter? Results expected Dec 2026 (estimated)
- Blood thinner danger: study probes hidden brain bleeds in stroke patients Results expected Dec 2026 (estimated)
-
Stem cells for failing livers: does the delivery route matter?
Disease control OngoingResearchers are testing whether human umbilical cord mesenchymal stem cells can help people with end-stage liver disease, and whether the route of delivery changes the outcome. Participants receive the cells either through a peripheral vein or through the hepatic artery. The tria…
Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Does the clock matter? trial tests endoscopy timing for cirrhosis bleeding
Disease control OngoingPeople with liver cirrhosis can develop dangerous bleeding from swollen veins in the esophagus or stomach. Doctors use endoscopy to find and treat the bleeding, but they do not know the best time to do it. This trial randomly assigns patients to different endoscopy timings to see…
Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Blood filter may boost stroke recovery
Disease control PausedThis study tests a blood-filtering device called DELP in people who have had a hemorrhagic stroke (bleeding in the brain). The filter removes fats and other substances from the blood to reduce brain swelling and damage. About 356 adults aged 18-80 with mild to moderate stroke sym…
Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Acid-blocking drug may reduce bleeding risk after variceal treatment in cirrhosis patients
Disease control By invitation onlyThis study looks at whether giving pantoprazole (a stomach acid reducer) after endoscopic treatment for enlarged veins in the esophagus or stomach can lower the chance of bleeding in people with liver cirrhosis. About 208 adults will take part. The goal is to see if short-term us…
Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC